Cargando…
Fabry Cardiomyopathy: Current Practice and Future Directions
Fabry disease (FD) is an X-linked lysosomal storage disorder caused by mutations in the galactosidase A (GLA) gene that result in deficient galactosidase A enzyme and subsequent accumulation of glycosphingolipids throughout the body. The result is a multi-system disorder characterized by cutaneous,...
Autores principales: | Yim, Jeffrey, Yau, Olivia, Yeung, Darwin F., Tsang, Teresa S. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233708/ https://www.ncbi.nlm.nih.gov/pubmed/34204530 http://dx.doi.org/10.3390/cells10061532 |
Ejemplares similares
-
Fabry Cardiomyopathy: Current Treatment and Future Options
por: Vardarli, Irfan, et al.
Publicado: (2021) -
Neuroimaging in Fabry disease: current knowledge and future directions
por: Cocozza, Sirio, et al.
Publicado: (2018) -
Cardiac abnormalities in Anderson-Fabry disease and Fabry’s cardiomyopathy
por: Morrissey, Ryan P, et al.
Publicado: (2011) -
Fabry Cardiomyopathy
por: Yoon, Jae Yong, et al.
Publicado: (2013) -
Myocarditis and inflammatory cardiomyopathy: current evidence and future directions
por: Tschöpe, Carsten, et al.
Publicado: (2020)